GetTopicDetailResponse(id=15053065088, topicName=再灌注率, introduction=再灌注率, content=null, image=null, comments=1, allHits=1143, url=https://h5.medsci.cn/topic?id=30650, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=97654, tagList=[TagDto(tagId=97654, tagName=再灌注率)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2129398, encodeId=0de42129398ab, content=這項研究提供了第三類證據(jù)，證明與<a href='/topic/show?id=b6e39e846c0' target=_blank style='color:#2F92EE;'>#阿替普酶#</a>相比，<a href='/topic/show?id=c77e6034264' target=_blank style='color:#2F92EE;'>#替奈普酶#</a>與由串聯(lián)病變引起的<a href='/topic/show?id=7a4a5236940' target=_blank style='color:#2F92EE;'>#急性缺血性卒中#</a>患者的顱內<a href='/topic/show?id=15053065088' target=_blank style='color:#2F92EE;'>#再灌注率#</a>、功能結局、死亡率和癥狀性顱內出血相似。不過，臨床上似乎是替奈普酶效果略好一些, objectTitle=Neurology：替奈普酶和阿替普酶治療串聯(lián)病變卒中患者的安全性和有效性: EXTEND-IA TNK 試驗的事后比較, objectType=article, longId=768445, objectId=87aee684455c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221121/1669073203857_4754896.jpeg, objectUrl=/article/show_article.do?id=87aee684455c, replyNumber=0, likeNumber=159, createdTime=2023-04-30, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=87aee684455c, moduleTitle=Neurology：替奈普酶和阿替普酶治療串聯(lián)病變卒中患者的安全性和有效性: EXTEND-IA TNK 試驗的事后比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=87aee684455c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
